Prehabilitation in colorectal cancer surgery improves outcome and reduces hospital costs.

Bibliographic Details
Title: Prehabilitation in colorectal cancer surgery improves outcome and reduces hospital costs.
Authors: Sabajo, Charissa R., ten Cate, David W.G., Heijmans, Margot H.M., Koot, Christian T.G., van Leeuwen, Lisanne V.L., Slooter, Gerrit D.
Source: European Journal of Surgical Oncology; Jan2024, Vol. 50 Issue 1, pN.PAG-N.PAG, 1p
Subject Terms: HOSPITAL costs, PROCTOLOGY, ONCOLOGIC surgery, COLORECTAL cancer, PREHABILITATION, ELECTIVE surgery
Abstract: Increasing evidence suggests that multimodal prehabilitation programs reduce postoperative complication rates and length of stay. Nevertheless, prehabilitation is not standard care yet, also as financial consequences of such programs are lacking. Aim of this study was to analyse clinical outcomes and effects on hospital resources if prehabilitation is implemented for patients who are planned for colorectal surgery. Patients undergoing elective colorectal surgery and who received either prehabilitation or standard care between January 2017 and March 2022 in a regional Dutch hospital were included. Outcome parameters were length of hospital stay, 30-day postoperative complications, 30-day ICU admission, readmission rates and hospital costs. A total of 196 patients completed prehabilitation whereas 390 patients received standard care. Lower overall complication rates (31 % vs 40 %, p = 0.04) and severe complication rates (20 % vs 31 %, p = 0.01) were observed in the prehabilitation group compared to standard care. Length of stay was shorter in the prehabilitation group (mean 5.80 days vs 6.71 days). In hospital cost savings were €1109 per patient, while the calculated investment for prehabilitation was €969. Implementation of a multimodal prehabilitation program in colorectal surgery reduces postoperative complication rates, length of stay and hospital costs. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Surgical Oncology is the property of W B Saunders and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Supplemental Index
More Details
ISSN:07487983
DOI:10.1016/j.ejso.2023.107302
Published in:European Journal of Surgical Oncology
Language:English